Copyright
©The Author(s) 2022.
World J Methodol. Jul 20, 2022; 12(4): 293-304
Published online Jul 20, 2022. doi: 10.5662/wjm.v12.i4.293
Published online Jul 20, 2022. doi: 10.5662/wjm.v12.i4.293
Table 3 Subgroup analyses of precancerous lesions and conditions showing pooled point prevalence before and after COTPA (2003) was enacted
| Period of study | LKP (95%CI) (Estimates) | ERP (95%CI) (Estimates) | PL (95%CI) (Estimates) | OSMF (95%CI) (Estimates) | LP (95%CI) (Estimates) |
| ≤ 2003 | 3.2 (2.5-4.0) (15) | No study; (0) | 5.2 (-3.2-13.6); (2) | 0.6 (0.4-0.7); (13) | 0.6 (0.2-1.0); (4) |
| > 2003 | 5.5 (5.2-5.9); (123) | 1.4 (1.0-1.7); (18) | 9.2 (7.5-10.8); (33) | 4.7 (4.4-5.0); (75) | 1.3 (1.1-1.4); (69) |
- Citation: Kumbhalwar A, Shetiya SH, Kakodkar P, Mehta V, Mathur A, Porwal P. Prevalence of precancerous lesions and conditions in India: A systematic review and meta-analysis. World J Methodol 2022; 12(4): 293-304
- URL: https://www.wjgnet.com/2222-0682/full/v12/i4/293.htm
- DOI: https://dx.doi.org/10.5662/wjm.v12.i4.293